Articles in section Research & Development
<< Opinion & Analysis | 447 articles | Royalties >> |
<< Previous | Pages 1 ..27 28 29 30 31 32 .. 45 | Next >> |
-
Medtronic and Eli Lilly in Drug-Device Pact for Parkinson’s Disease
-
Pfizer Continues its Pursuit of Rare Disease Therapies with Zacharon Collaboration
-
Gilead Sciences and Yale School of Medicine in Potential US$100 M Cancer Research Pact
-
Abbott Becomes Seattle Genetics’ Latest Antibody-Drug Conjugate Collaborator
-
Epizyme Signs its Second Major Deal of 2011
-
Lycera and Merck & Co. to Develop Autoimmune Disease Drugs Targeting Th17 Cells
-
Anacor and Medicis in US$160 M Acne Research Pact
-
Theraclone Sciences Signs its First Major Antibody Deal with Pfizer
-
Merck Serono and Domain Therapeutics Partner to Develop Positive Allosteric Modulators for Parkinson’s Disease
-
Pfizer Licenses Seattle Genetics’ Antibody-Drug Conjugate Technology